BIO - Life sciences tools companies higher as NIH pauses cancellation of research grants
2025-06-25 18:12:53 ET
More on Thermo Fisher Scientific, Illumina
- Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
- Thermo Fisher Is Strengthening Its Long-Term Advantage
- Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)
- Standard BioTools jumps on sale of SomaLogic to Illumina
- 5 stocks to watch on Friday: X, SNPS, ANSS, AAPL and TMO